期刊文献+

Exploring the Nicotinic Acetylcholine Receptor-associated Proteome with iTRAQ and Transgenic Mice 被引量:1

Exploring the Nicotinic Acetylcholine Receptor-associated Proteome with iTRAQ and Transgenic Mice
原文传递
导出
摘要 Neuronal nicotinic acetylcholine receptors (nAChRs) containing Gt4 and 132 subunits are the principal receptors in the mammalian central nervous system that bind nicotine with high affin- ity. These nAChRs are involved in nicotine dependence, mood disorders, neurodegeneration and neuroprotection. However, our understanding of the interactions between a4β2-containing (a4β2) nAChRs and other proteins remains limited. In this study, we identified proteins that inter- act with ct4β2 nAChRs in a gene-dose dependent pattern by immunopurifying β2 nAChRs from mice that differ in ct4 and β2 subunit expression and performing proteomic analysis using isobaric tags for relative and absolute quantitation (iTRAQ). Reduced expression of either the a4 or the β2 subunit results in a correlated decline in the expression of a number of putative interacting proteins. We identified 208 proteins co-imrnunoprecipitated with these nAChRs. Furthermore, stratified lin- ear regression analysis indicated that levels of 17 proteins was correlated significantly with expres- sion of at4β2 nAChRs, including proteins involved in cytoskeletal rearrangement and calcium signaling. These findings represent the first application of quantitative proteomics to produce a β2 nAChR interactome and describe a novel technique used to discover potential targets for pharma- cological manipulation of a4β2 nAChRs and their downstream signaling mechanisms. Neuronal nicotinic acetylcholine receptors (nAChRs) containing Gt4 and 132 subunits are the principal receptors in the mammalian central nervous system that bind nicotine with high affin- ity. These nAChRs are involved in nicotine dependence, mood disorders, neurodegeneration and neuroprotection. However, our understanding of the interactions between a4β2-containing (a4β2) nAChRs and other proteins remains limited. In this study, we identified proteins that inter- act with ct4β2 nAChRs in a gene-dose dependent pattern by immunopurifying β2 nAChRs from mice that differ in ct4 and β2 subunit expression and performing proteomic analysis using isobaric tags for relative and absolute quantitation (iTRAQ). Reduced expression of either the a4 or the β2 subunit results in a correlated decline in the expression of a number of putative interacting proteins. We identified 208 proteins co-imrnunoprecipitated with these nAChRs. Furthermore, stratified lin- ear regression analysis indicated that levels of 17 proteins was correlated significantly with expres- sion of at4β2 nAChRs, including proteins involved in cytoskeletal rearrangement and calcium signaling. These findings represent the first application of quantitative proteomics to produce a β2 nAChR interactome and describe a novel technique used to discover potential targets for pharma- cological manipulation of a4β2 nAChRs and their downstream signaling mechanisms.
出处 《Genomics, Proteomics & Bioinformatics》 SCIE CAS CSCD 2013年第4期207-218,共12页 基因组蛋白质组与生物信息学报(英文版)
基金 supported by the National Institutes of Health (NIH) [Grant No. DA14241, DA018343 (to NIDA Proteomics Center at Yale University) and UL1 RR024139 (to Yale Clinical and Translational Science Award)] supported by NIH (Grant No. T32 MH014276) JML was supported by NIH (Grant No. NS11323) MJM and SRG were supported by NIH (Grant No. DA003194 and DA015663)
关键词 Nicotinic receptor Affinity purification Quantitative proteomics Transgenic mouse Nicotinic receptor Affinity purification Quantitative proteomics Transgenic mouse
  • 相关文献

参考文献54

  • 1Whiting P J, Lindstrom JM. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclo- nal antibodies. J Neurosci 1988;8:3395-404.
  • 2Zoli M, L6na C, Picciotto MR, Changeux JP. Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 1998;18:4461-72.
  • 3Gotti C, Moretti M, Meinerz NM, Clementi F, Gaimarri A, Collins AC, et al. Partial deletion of the nicotinic cholinergic receptor alpha 4 or beta 2 subunit genes changes the acetylcholine sensitivity of receptor-mediated ^86Rb^+ efflux in cortex and thalamus and alters relative expression of alpha 4 and beta 2 subunits. Mol Pharmacol 2008:73:1796-807.
  • 4Picciotto MR, Zoli M, Lana C, Bessis A, Lallemand Y, Le Novare N, et al. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 1995;374:65-7.
  • 5Millar NS, Gotti C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 2009;56:237-46.
  • 6Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103.
  • 7Ago Y, Koda K, Takuma K, Matsuda T. Pharmacological aspects of the acetylcholinesterase inhibitor galantamine. J Pharmacol Sci 2011;116:6-17.
  • 8Quik M, Wonnacott S. α6β2^* and α4β2^* nicotinic acetylcholine receptors as drug targets for Parkinson's disease. Pharmacol Rev 2011 ;63:938-66.
  • 9Mineur YS, Picciotto MR. Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis of depression. Trends Pharmacol Sci 2010;31:580-6.
  • 10Bacher I, Rabin R, Woznica A, Sacco KA, George TP. Nicotinic receptor mechanisms in neuropsychiatric disorders: therapeutic implications. Primary Psychiatry 2010;17:35-41.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部